SVNS.
34 announcements.
34 announcements.
Time | Date | Ticker | Company | Announcement |
---|---|---|---|---|
07:00 | 23-06-2025 | SVNS | SVNS | Allowance of U.S. patent covering AI-supported CNS |
07:30 | 11-06-2025 | SVNS | SVNS | Initiation of AI supported CNS drug discovery |
07:00 | 05-06-2025 | SVNS | SVNS | Synthesis of development candidate for SVN-SDN-014 |
16:30 | 03-06-2025 | SVNS | SVNS | Notice of Annual General Meeting |
07:00 | 03-06-2025 | SVNS | SVNS | Appointment of Prof. David Nutt as CSO |
11:58 | 02-06-2025 | SVNS | SVNS | Holding(s) in Company |
17:00 | 30-05-2025 | SVNS | SVNS | Total Voting Rights |
15:11 | 29-05-2025 | SVNS | SVNS | Holding(s) in Company |
12:02 | 29-05-2025 | SVNS | SVNS | Holding(s) in Company |
10:30 | 29-05-2025 | SVNS | SVNS | Holding(s) in Company |
07:00 | 29-05-2025 | SVNS | SVNS | Presentation at Mello2025 |
07:30 | 28-05-2025 | SVNS | SVNS | Holding(s) in Company |
07:00 | 28-05-2025 | SVNS | SVNS | Completion of the acquisition of Awakn |
15:24 | 21-05-2025 | SVNS | SVNS | Publication of a Prospectus |
07:31 | 16-05-2025 | SVNS | SVNS | Result of placing |
16:53 | 15-05-2025 | SVNS | SVNS | Proposed equity fundraising via ABB |
11:30 | 28-04-2025 | SVNS | SVNS | Result of General Meeting |
07:00 | 23-04-2025 | SVNS | SVNS | Proposed acquisition of Awakn approved |
07:00 | 16-04-2025 | SVNS | SVNS | Final Results for the year ended 31 December 2024 |
14:00 | 10-04-2025 | SVNS | SVNS | Posting of Circular and Notice of General Meeting |
07:00 | 07-04-2025 | SVNS | SVNS | Holding(s) in Company |
07:00 | 04-04-2025 | SVNS | SVNS | Engagement of PharmaVentures |
07:00 | 26-03-2025 | SVNS | SVNS | Positive progress on European Patent Application |
07:00 | 18-03-2025 | SVNS | SVNS | Update on AWKN-SDN-14 programme |
09:00 | 11-03-2025 | SVNS | SVNS | Holding(s) in Company |
07:00 | 11-03-2025 | SVNS | SVNS | Appointment of Non-Executive Director |
07:00 | 25-02-2025 | SVNS | SVNS | Presentation at PharmaSynergyRx Event |
07:00 | 24-02-2025 | SVNS | SVNS | Entry into an Arrangement Agreement with Awakn |
12:00 | 30-01-2025 | SVNS | SVNS | Proactive Investors interview with Chairman |
07:00 | 27-01-2025 | SVNS | SVNS | Update on Awakn Life Sciences’ R&D Progress |
07:00 | 24-01-2025 | SVNS | SVNS | Investor Presentation |
14:29 | 21-01-2025 | SVNS | SVNS | Proactive Investors interview with CEO |
07:00 | 21-01-2025 | SVNS | SVNS | Update on FDA Pre-IND Meeting for Awakn |
07:00 | 15-01-2025 | SVNS | SVNS | Interview with CEO |